Director · NovaBridge Biosciences · Ordinary Shares
Side
M
Value
—
Shares
17.2K
Price
—
Executed
Aug 22, 2026
Disclosed
Aug 25, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Aug 22 executedAug 25, 2026 disclosed
NBP · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lenz Robert A. filed this Form 4 reporting a option exercise of NBP on Aug 22, 2026. It became public on Aug 25, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Lenz Robert A.cik:0001992908
Issuer
NovaBridge Biosciencescik:0001778016
Revision history · 0
No field has changed since this record was first ingested.
